Taysha Gene Therapies (TSHA) Reports In-Line Q3 EPS

Go back to Taysha Gene Therapies (TSHA) Reports In-Line Q3 EPS
(NASDAQ: TSHA) Delayed: 6.09 -0.02 (0.33%)
Previous Close $6.11    52 Week High
Open $6.18    52 Week Low
Day High $6.24    P/E N/A 
Day Low $6.02    EPS
Volume 2,831,062